piribedil has been researched along with Intermittent Claudication in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Intermittent Claudication: A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Royer, RJ | 1 |
| Milliken, JC | 1 |
| Fares, CM | 1 |
| O'Connor, D | 1 |
2 trials available for piribedil and Intermittent Claudication
| Article | Year |
|---|---|
[Objective data on the action of piribedil in disorders of the peripheral arterial circulation].
Topics: Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Diabetic Angiopathies; Drug Eval | 1976 |
[Double-blind study on piribedil in peripheral arterial diseases].
Topics: Arterial Occlusive Diseases; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Huma | 1976 |